EMA Custom Webtools Rating widget: Hidden by field_ema_hide_rating for this node.
Diabetes
This page brings together the European Medicines Agency's (EMA) latest information on diabetes.
Bulgarian is available via eTranslation, the European Commission's machine translation service.
Translate to Bulgarian | Important information about machine translation
It lists the following:
- the newest and most recently updated medicines authorised for diabetes in the European Union
- EMA's latest diabetes-related news announcements
- EMA's upcoming events on diabetes-related topics
We are currently unable to display the new and recently updated medicines authorised for diabetes due to a technical error. We are working to resolve the issue as soon as possible. We apologise for any inconvenience caused.
Latest news
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 July 2024
PRAC elects new chair
12 July 2024
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 April 2024
GLP-1 receptor agonists: available evidence not supporting link with suicidal and self-injurious thoughts and actions
12 April 2024
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 November 2023
PRAC recommends measures to minimise the risk of serious side effects with medicines containing pseudoephedrine.
1 December 2023
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 6-9 November 2023
EMA’s human medicines committee (CHMP) recommended eight medicines.
10 November 2023
Events of interest
Currently, we have no events for this therapeutic area.